Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

Rhea-AI Summary

Kymera Therapeutics (NASDAQ: KYMR) will report third quarter 2025 financial results on November 4, 2025.

The company will host a video conference call and livestreamed webcast on November 4, 2025 at 8:30 a.m. ET. Investors can register to join the video call or view the webcast via the company’s Investors > News and Events page at www.kymeratx.com. A replay of the webcast will be archived and available after the event.

WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2025 financial results on November 4, 2025. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.

To join the video call or view the livestreamed webcast, please register via this link, or visit “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.

About Kymera Therapeutics 
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X or LinkedIn.

Investor and Media Contact:  Justine Koenigsberg Vice President, Investor Relations investors@kymeratx.com media@kymeratx.com 857-285-5300

FAQ

When will Kymera Therapeutics (KYMR) report third quarter 2025 results?

Kymera will report Q3 2025 financial results on November 4, 2025.

What time is the Kymera (KYMR) Q3 2025 conference call and webcast?

The video conference call and webcast are scheduled for November 4, 2025 at 8:30 a.m. ET.

How can investors join the Kymera (KYMR) webcast on November 4, 2025?

Investors can register for the video call or view the livestream via the company’s Investors > News and Events page at www.kymeratx.com.

Will a replay of the Kymera (KYMR) Q3 2025 webcast be available after the event?

Yes, a replay of the webcast will be archived and available following the event on the company website.

Where can I find registration and the replay for Kymera (KYMR) Q3 2025 results?

Registration and the archived replay will be accessible on Kymera’s Investors > News and Events page at www.kymeratx.com.